PRPH (PRPH) Stock Price & Analysis
PRPH (PRPH) rose 0.00% to USD 0.02 as of September 8, 2026 at 11:14 UTC, according to Nexqual real-time market data.
PRPH last closed at USD 0.02; the session ranged USD 0.02–0.02 on volume of 42,314 shares. Market capitalization is —, with a 52-week range of USD 0.02–6.7 (OID). Source: Nexqual, September 8, 2026 at 11:14 UTC.
Key Statistics (as of September 8, 2026 at 11:14 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0.02 – 6.7 |
| Volume | 42,314 shares |
| Market Cap | — |
| Exchange | OID |
Technical Analysis (PRPH)
Nexqual's technical model rates PRPH "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 11:14 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.16 (neutral) |
| vs SMA50 | Below (USD 0.05) |
| MACD | -0.01 (negative) |
From PRPH's Latest SEC 10-K Filing (filed 2026-06-01)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CPIX | Cumberland Pharmaceuticals Inc. | USD 6.79 | ▲ 4.14% |
| NAII | Natural Alternatives Internatio | USD 2.08 | ▼ 1.89% |
| XTLB | XTL Biopharmaceuticals Ltd. | USD 2.53 | ▼ 4.89% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| ICCC | ImmuCell Corporation | USD 9.9 | ▼ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 11:14 UTC. This page is informational and not investment advice.